Pancreatic Cancer Research

ResearcherNorth Sichuan Medical UniversityNo recent work listed

Jian Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9750-7689; OpenAlex author ID A5100760829. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2021: 7 papers · 2022: 3 papers · 2023: 1 paper

Papers 11

  1. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway. First author DOI 10.1038/s41419-023-05871-4↗
  2. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis. Co-author DOI 10.1016/j.canlet.2022.215751↗
  3. LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2. Co-author DOI 10.1038/s41419-022-05172-2↗
  4. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. First author DOI 10.1038/s41420-022-01061-x↗
  5. Long noncoding RNA LINC00941 promotes pancreatic cancer progression by competitively binding miR-335-5p to regulate ROCK1-mediated LIMK1/Cofilin-1 signaling. Co-author DOI 10.1038/s41419-020-03316-w↗
  6. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer. Co-author DOI 10.1038/s41419-021-03921-3↗
  7. Circular RNA hsa_circ_0006117 Facilitates Pancreatic Cancer Progression by Regulating the miR-96-5p/KRAS/MAPK Signaling Pathway. Co-author DOI 10.1155/2021/9213205↗
  8. [6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling. Co-author DOI 10.1186/s12935-021-02118-0↗
  9. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway. Co-author DOI 10.1186/s12935-021-02222-1↗
  10. EZR Promotes Pancreatic Cancer Proliferation and Metastasis by Activating FAK/AKT Signaling Pathway Co-author DOI 10.21203/rs.3.rs-770494/v2↗
  11. Hypoxia-Induced ZWINT Mediates Pancreatic Cancer Proliferation by Interacting With p53/p21. Co-author DOI 10.3389/fcell.2021.682131↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianxin Jiang · 9 shared papers, 2021–2023 · strength 1.53
  2. Xinyuan Liu · 6 shared papers, 2021–2023 · strength 1.06
  3. Xueyi Jiang · 6 shared papers, 2021–2022 · strength 0.90
  4. Zhiwei He · 5 shared papers, 2021–2022 · strength 0.77
  5. Yankun Chen · 5 shared papers, 2021–2022 · strength 0.72
  6. Jichuan Xu · 2 shared papers, 2022–2023 · strength 0.46
  7. Jie Wang · 2 shared papers, 2021–2022 · strength 0.35
  8. Zhiwei He · 2 shared papers, 2021–2022 · strength 0.30
  9. Jie Wang · 2 shared papers, 2021 · strength 0.28
  10. Wei Zhang · 1 shared paper, 2021 · strength 0.28
  11. Peng Chen · 2 shared papers, 2021 · strength 0.28
  12. Wei Zhang · 1 shared paper, 2021 · strength 0.28
  13. Gang Quan · 1 shared paper, 2022 · strength 0.17
  14. Cheng-Yi Sun · 1 shared paper, 2022 · strength 0.16
  15. Tao Liu · 1 shared paper, 2021 · strength 0.15
  16. Peng Chen · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.